| abstract |
The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the text sample is indicative of an IBD in the mammalian subject from which the test sample was obtained. |